BRCA2 and breast cancer: This study elegantly demonstrates that a single metabolite, Methylglyoxal (MGO)—derived nonenzymatically from glyceraldehyde-3-phosphate mainly during glycolysis—can act as an oncogene by transiently inactivating Breast cancer type 2 (BRCA2).